Recombinant TIGIT (Ociperlimab Biosimilar) antibody
The Human Monoclonal anti-TIGIT (Ociperlimab Biosimilar) antibody is suitable to detect TIGIT (Ociperlimab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.
Catalog No. ABIN7676027
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant TIGIT (Ociperlimab Biosimilar) antibody (ABIN7676027)
Target
TIGIT (Ociperlimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This TIGIT (Ociperlimab Biosimilar) antibody is un-conjugated
Application
Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-TIGIT Reference Antibody (ociperlimab)
-
Characteristics
- Anti-TIGIT Reference Antibody (ociperlimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- TIGIT (Ociperlimab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- Q495A1
Target
-
You are here:
